US medtech group issues guiding principles for device DTC ads
This article was originally published in SRA
US medtech industry association AdvaMed has for the first time issued a set of voluntary guiding principles for the direct-to-consumer advertising of medical devices1,2. The 13 guiding principles, which are designed to ensure that DTC advertising for devices provides the most accurate and meaningful information for patients, “set a high bar” for the responsible use of DTC advertising by device companies, says AdvaMed.
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.